We are delighted to welcome Dr Kim Champion to the Boyds team as Regulatory Affairs Manager.
With extensive experience in the Clinical Operations sphere, Kim will help prepare regulatory documentation and provide operational support to sponsors in all stages of drug development.
After moving from Switzerland to England in 1990, Kim began her career as a Research Assistant at the University of Cambridge, and from there went on to work at the European Society for Blood and Marrow Transplantation (EBMT), progressing from Trial Coordinator to Acting Director for Clinical Trials Operations. During this time, she built up the organisation’s clinical trials team and oversaw a portfolio of European phase 2-3 trials in cancer, haematological, neurological and autoimmune disorders.
In 2010, Kim joined University College London (UCL) as Regulatory Manager for ATMP trials in the Joint Research Office. From there, she moved to the Cancer Research UK & UCL Cancer Trials Centre as a Trial Group Lead for ATMP trials, establishing UCL’s first trials team specialising solely in gene and cell therapies. During her time at UCL, she collaborated with companies such as Autolus and bluebird bio.
Commenting on her appointment at Boyds, Kim said:
“I am delighted to join Boyds’ growing Regulatory Affairs team as Regulatory Affairs Manager. Having spent ten years working exclusively in Phase 1 & 2 clinical trials with advanced therapy medicinal products (ATMPs), I am well versed in successfully setting up and managing clinical trials in accordance with current legal and regulatory requirements.”
Professor Alan Boyd added:
“Kim is a highly skilled Regulatory Affairs Manager with an abundance of experience in supporting scientists and physicians in bringing academically developed ATMPs into the clinic. Demand for our regulatory services continues to grow, and we are thrilled to welcome Kim to the Regulatory Affairs team here at Boyds.”
